The drug interaction potential of berberine hydrochloride when co-administered with simvastatin, fenofibrate, gemfibrozil, metformin, glimepiride, nateglinide, pioglitazone and sitagliptin in beagles
Berberine (BBR) hydrochloride is a traditional Chinese medicine with unique hypoglycemic and lipid-lowering effects discovered in recent years. The combination of BBR with other hypoglycemic drugs and lipid-lowering drugs could become a promising treatment strategy. With the aim of evaluating the po...
Enregistré dans:
Auteurs principaux: | Guofei Li, Mingming Zhao, Limei Zhao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/24aeca21ebfd4983ae8e9efb1e32ff5f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics
par: Zhao J, et autres
Publié: (2021) -
Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine
par: Xiong W, et autres
Publié: (2018) -
Application of Physiologically Based Pharmacokinetic Modeling to Evaluate the Drug–Drug and Drug–Disease Interactions of Apatinib
par: Hongrui Liu, et autres
Publié: (2021) -
Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
par: Dkhi,Mohamed A
Publié: (2014) -
Retrospective analysis of clinical outcomes of patients with COVID-19 depending on receiving antihypertensive, lipid-lowering and antihypertensive therapy
par: Tatiana Yu. Demidova, et autres
Publié: (2021)